Mike Horne-
Managing Partner

Mike brings a network of high net worth individuals, and broad experience within and supporting startups across industries. Mike got his start at Wasatch Advisors, a Utah investment firm with $15B under management. After two years in their research department, he got the entrepreneurship bug, and has since started six companies, expanded two to multiple states, and raised capital and eventually sold three of them. Through all his startup experience he realized that he’s at his best working with small teams and helping businesses scale and raise capital, and less interested in running them once they scale. So he stopped going into business for himself and started coaching companies through their own raise efforts. Mike has successfully raised millions of dollars in Angel and Seed rounds from venture capital institutions.

Eric B. Hale-
Capital Strategy

Eric B. Hale has spent more than 30 years in senior management positions at Fortune 50, mid-sized and early stage companies including nearly 20 years at the CEO level. He has raised capital through private equity, venture capital and private investment and has taken two life science companies successfully through their initial public stock offerings on NASDAQ. He has broad experience in dealing with products and services that require government agency approvals and oversight including but not limited to, FDA, EPA, USDA and EU. He is well versed in strategy development and execution; mergers and acquisitions, product licensing both in and out; new market development, evaluating and commercializing complex technologies and exit strategy. He also has broad and deep experience in medical devices, healthcare services, biotechnology and biopharmaceuticals and medical manufacturing.

Eric has made direct investments in or provided strategic advisory services to a number of healthcare products companies including: Coherex Medical (acquired by J&J), Olive Medical (acquired by J&J), Provide Nutrition, (acquired by Frog Fuel) and sBioMed. He has also advised Grandeur Peak, an international small cap investment fund on selected life science companies.